Monday, October 07, 2024 10:09:17 PM
The slope of the indicator is positive and suggests that buyers are presently more active than sellers.Today's volume was heavier than usual, trading 2,320,021 shares, versus an average of 389,835 shares per day during the last twelve months.
Recent CUE News
- Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/29/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2024 09:00:05 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2024 09:00:03 PM
- Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/25/2024 01:00:00 PM
- Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 11/14/2024 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:00:09 PM
- Cue Biopharma Announces Strategic Organizational Transition • GlobeNewswire Inc. • 11/14/2024 01:00:09 PM
- Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting • GlobeNewswire Inc. • 11/08/2024 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 08:00:08 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/07/2024 09:07:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:00:07 PM
- Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting • GlobeNewswire Inc. • 10/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:17:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/27/2024 08:05:39 PM
- Cue Biopharma Announces Pricing of $12.0 Million Public Offering • GlobeNewswire Inc. • 09/27/2024 03:26:30 AM
- Cue Biopharma Announces Proposed Public Offering • GlobeNewswire Inc. • 09/27/2024 03:10:15 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/26/2024 08:32:08 PM
- Cue Biopharma Announces Proposed Public Offering • GlobeNewswire Inc. • 09/26/2024 08:27:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/10/2024 08:00:02 PM
- Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer • GlobeNewswire Inc. • 09/09/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:30:09 PM
Consumer Automotive Finance, Inc. Announces Cancellation of 200 Million Common Shares and Updates on Name and Ticker Symbol Change • CAFI • Dec 6, 2024 12:45 PM
4Cable TV International, Inc. (OTC.PK: CATV) Signs Letter of Intent to Acquire MariJ Pharmaceuticals from Branded Legacy, Inc. and Retains New Counsel for Name Change with FINRA • CATV • Dec 6, 2024 8:00 AM
Bantec's Howco Distributing Co. and Bantec Environmental Corp. Win Contracts • BANT • Dec 5, 2024 10:00 AM
Kona Gold Beverage, Inc. Announces Strategic Reorganization and a Bold New Direction • KGKG • Dec 5, 2024 9:33 AM
Branded Legacy, Inc. Strengthens Biotech Leadership, Focuses on Expansion, and Advances Strategic Rebranding • BLEG • Dec 5, 2024 8:30 AM
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM